Blog /

Patient Story

Receive stem cell information via email

Want to learn more about treatment? View our protocol.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Blog / Stem Cells

COVID-19 Patient in Critical Condition Successfully Treated with Mesenchymal Stem Cells


January 14, 2021

COVID-19 Patient in Critical Condition Successfully Treated with Mesenchymal Stem Cells

David Lyons

Guest contributor

Jan 14, 2021

Louis A. Cona, MD

Medical Director | DVC Stem

A new press release by Vitro Biopharma a CLIA, ISO9001, ISO13485 certified laboratory in Golden, Colorado, USA, has announced a remarkable COVID-19 patient recovery after being treated with expanded cord tissue-derived mesenchymal stem cells.

The current global state of COVID-19 is looming over many. Daily news reports, Facebook posts & blog articles express a gloomy future outlook that can cause anxiety and stress among many.

However, encouraging news and data does sometimes find its way into the public sphere.  Mesenchymal stem cells are beginning to show promise as a potential treatment for COVID-19.  

A new press release by Vitro Diagnostics, Inc, dba Vitro Biopharma a CLIA, ISO9001, ISO13485 certified laboratory in Golden, Colorado, USA, has announced a remarkable COVID-19 patient recovery after being treated with expanded cord tissue-derived mesenchymal stem cells.

The patient initially admitted into an emergency room with traditional COVID-19 symptoms.  The patient had several comorbidities (more than one pre-existing medical condition) before hospital admission.  Doctors initially used a standard treatment (yet still experimental) with convalescent plasma, but the patient's condition continued to worsen.  While in the intensive care unit (ICU), the patient's liver and kidney functions began to fail. The patient also experienced sepsis and a stroke, cumulatively placing the patient in a coma for almost seven weeks. 

Stem cell treatment for COVID-19

The FDA authorized a study through an Investigational Drug Application (eIND) for emergency use of Vitro Biopharma's AlloRx Stem Cells® (cord tissue-derived mesenchymal stem cells) as a therapeutic agent.

Following the treatment with Vitro Biopharma's culturally expanded cord tissue-derived mesenchymal stem cells, the patient experienced resolution of multiple organ function failure, recovery from coma and restoration of neurological, pulmonary, liver, and renal function. (1) Resulting in the patient being removed from dialysis and assissted respiration machines.  

The patient has not only gained the ability to eat, drink, and speak but has also regained motor function.  The patient's inflammation levels have also dropped back down to normal.  The patient has now been discharged from the intensive care unit and follows a physical therapy regime to improve mobility.

According to Dr. Jack Zamora, MD, Vitro Biopharma's Chief Medical Advisor: 

"The miraculous recovery of our first critically ill COVID-19 patient using AlloRx Stem Cells brings great hope in these troubling times."

This recovery shows the exciting promise of mesenchymal stem cells' ability to treat inflammation and help resolve issues such as organ failure.  The natural immunomodulatory capabilities of Mesenchymal Stem Cells may be among the most effective ways to reduce inflammatory cytokine damage in the lungs caused by COVID-19.

Dr. Jim Musick, CEO of Vitro Biopharma, states:

"We are pleased to have achieved this milestone based on a thorough understanding of the science of stem cell biology. While regeneration of destroyed cells is a common effect of stem cell therapy, stem cells also regenerate damaged cells by various regenerative processes that restore normal organ function. This case supports the further study of AlloRx Stem Cell® Therapy for COVID-19 patients and other conditions characterized by acute respiratory distress that are ultimately related to the inflammatory cytokine cascade neutralized by the cord tissue-derived mesenchymal stem cells. "

Learn more about DVC Stem

DVC Stem is partnered with Vitro Biopharma, an award-winning medical laboratory located in Golden, Colorado, fully FDA-registered, cGMP compliant, ISO 9001, and ISO 13485 certified. Cells are only sourced from the American Association of Tissue Bank (AATB) certified suppliers of full-term, ethically US donated human umbilical cords. The selection of these donated tissues is exceptionally regulated and strict. All of its cells are expanded using safe and standard protocols and are then flown overnight in sub-zero containers directly to our clinic for immediate treatment. The cells are expanded to as many as 300 million cells before being administered. For more info on its partner lab, visit


(1) Critically Ill COVID-19 Patient Successfully Treated with Vitro Biopharma's AlloRx Stem Cells®. 15 July 2020,

"Dr. Cona is a leading edge stem cell treatment physician"

Matthew Murry - MS Patient


"Is the video I posted from this morning! My speech is so easy for me now, got easier throughout the day! I can talk like a NYer (fast) for the first time in years! Praise God!"

- Matthew Murry


Only 3 days after treatment, Matthew is now able to touch his nose with his eyes closed as well as touch his thumb and pinky together. Both of which he was previously unable to do before treatment.

We are excited to see his continued progress. His story will be updated here so keep an eye out!

Matthew showing his progress with mobility

Matthew Murry - 3 days post treatment

"This is exciting stuff, god bless"

Matthew Murry - MS Patient


Matthew experiences sensation in the bottom of his feet after receiving a simple nerve test.

His left foot did not experience any sensation or move at all, but what happened to his right foot is extremely exciting!


Matthew is now able to lift his leg unassisted. He was previously unable to do so.

Matthew is experiencing the benefits of stem cell therapy first hand. You can view his progress video here.

Matthew showing some amazing mobility improvements.

Matthew Murry - 50 days post treatment

"Amazing progress from one of our MS patients Matthew Murray"

Louis A. Cona, MD - DVC Stem


Matthew is able to stand up with the assistance of stability bars.

David Lyons

Multiple Sclerosis

Although David Lyons was able to successfully fight Multiple Sclerosis through a strict regimen of diet and exercise, he wanted to ensure he was doing everything he could to stay fit. Multiple Sclerosis can be managed with treatment, but there is currently no cure for the disease. For that reason, David came to DVC Stem years ago to use the regenerative and anti-inflammatory attributes of stem cells to aid in his fight for fitness.

The positive results he experienced enabled David to stay strong in the gym, now into his 60s, and that is why he continues to support our clinic to this day.

About the author

Louis A. Cona, MD

Louis A. Cona, MD

Dr. Cona has been performing stem cell therapy for over 10 years. He is a member of the World Academy of Anti-Aging Medicine (WAAAM). He is also a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians. He is the Medical Director for DVC Stem a world-renowned stem cell therapy clinic located in Grand Cayman.

Are you a candidate for stem cell treatment?

Complete our brief online application to find out if our IRB-approved mesenchymal stem cell treatment is right for you.

Apply for treatment

You might also like...